Goodwin advised Generate:Biomedicines on the fundraising. Generate:Biomedicines announced that it has raised $273 million in Series C financing. This financing round attracted many new investors including...
You must be a Standard 1 Year member to access this content.
Goodwin advised Dynatrace on the deal. Dynatrace (NYSE: DT) announced it has signed a definitive agreement to acquire Rookout. The addition of Rookout to the Dynatrace®...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised PointClickCare Corp. on the deal. PointClickCare Corp. announced its acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies’...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Ping Identity, while Goodwin Procter represented Thoma Bravo in the transaction. Ping Identity (NYSE: PING), provider of the Intelligent Identity solution for...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Thoma Bravo, while Goodwin Procter advised SailPoint Technologies Holdings, Inc. on the deal. Latham & Watkins represented the direct lenders in the...
You must be a Standard 1 Year member to access this content.
Goodwin advised Generate Biomedicine on the deal. Generate Biomedicines announced its research collaboration agreement with Amgen (NASDAQ: AMGN) to discover and create protein therapeutics for five clinical...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Gernandt & Danielsson advised Cint Group AB on the deal, while Goodwin Procter represented Lucid Holdings, LLC. Cint Group AB (publ), a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
